THV Expansion

By Ted E. Feldman, MD, MSCAI, FACC, FESC

Sapien Valve: Past, Present, and Future

A look at how the Sapien family of valves continues to evolve to treat a range of patients seeking transcatheter aortic valve replacement.

By Ravinder Singh Rao, MD; Hersh Maniar, MD; and Alan Zajarias, MD

CoreValve Update

The current status and next generation of the CoreValve system.

By Rajiv Goswami, DO, and Neal S. Kleiman, MD

Lessons From the TVT Registry

An assessment of the TVT registry, which is studying the real-world outcomes of patients undergoing new valvular therapies.

By David R. Holmes, MD, and Michael J. Mack, MD

Valve-in-Valve Transcatheter Aortic and Mitral Replacement

Expert opinions on the United States experience with valve-in-valve transcatheter aortic and mitral valve replacement techniques.

By Jose F. Condado, MD, MS; Brian Kaebnick, MD; and Vasilis Babaliaros, MD

TAVR in Intermediate-Risk Patients

What the results from ongoing randomized trials may tell us about expanding TAVR to lower-risk patients.

By Arash Arshi, MD, FACC; Daniel R. Watson, MD; and Steven J. Yakubov, MD, FACC

Current Status of MitraClip

A review of the available data on the utility of this device for treating functional mitral regurgitation.

By Peter S. Fail, MD, FACC, FACP, FSCAI, and Vinod Nair, MD, FACC, FSCAI

Early Experience With Transcatheter Mitral Valve Replacement

The current status of this novel technique to treat patients with severe mitral disease who are not candidates for surgery.

By Mayra Guerrero, MD, FACC, FSCAI; Adam B. Greenbaum, MD, FACC, FSCAI; and William O'Neill, MD, FACC, FSCAI

Ask the Experts: Should the CMS NCD Requirement for Surgical and Interventional Co-Operators for TAVR Procedures Be Dropped?

With John C. Alexander, MD; Atul Chawla, MD; David X. Zhao, MD; Nirat Beohar, MD, FACC, FSCAI; and Mohamed Abdel-Wahab, MD, FESC

From Door-to-Balloon to Door-to-Unload Time

An emerging view on the management of STEMI complicated by cardiogenic shock.

By Navin K. Kapur, MD

Expansion in a Time of Consolidation

With cost-cutting efforts underway at nearly every hospital, facility expansion and investment in new capital equipment might seem a tough sell to hospital administrators. But, that's just what Barry T. Katzen, MD, and Miami Cardiac & Vascular have been working toward. Dr. Katzen discusses the institute's decision to initiate a $120 million expansion, as well as the challenges of seeing the plan through in a daunting financial climate.

Discharge Management of Patients With Diabetes and ACS

Optimizing long-term outcomes.

By Suzanne V. Arnold, MD, MHA, and Mikhail Kosiborod, MD

Innovations

A preview of today's new products.

An Interview With Sameer Gafoor, MD

Dr. Gafoor discusses his work at CardioVascular Center Frankfurt and some tips, tricks, and predictions for structural heart intervention.